HRP20180452T1 - Peptidi - Google Patents

Peptidi

Info

Publication number: HRP20180452T1
Authority: HR; Croatia
Prior art keywords: peptides
Prior art date: 2013-08-06

Application number

HRP20180452TT

Other languages

English (en)

Inventor

David Wraith

Original Assignee

Apitope International Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-06

Filing date

2018-03-16

Publication date

2018-06-01

2018-03-16 Application filed by Apitope International Nv filed Critical Apitope International Nv

2018-06-01 Publication of HRP20180452T1 publication Critical patent/HRP20180452T1/hr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HRP20180452TT 2013-08-06 2018-03-16 Peptidi HRP20180452T1 (hr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB201314052A GB201314052D0 (en)	2013-08-06	2013-08-06	Peptides
PCT/IB2014/063739 WO2015019302A2 (en)	2013-08-06	2014-08-06	Peptides
EP14772444.7A EP3030259B1 (en)	2013-08-06	2014-08-06	Peptides

Publications (1)

Publication Number	Publication Date
HRP20180452T1 true HRP20180452T1 (hr)	2018-06-01

Family

ID=49224229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HRP20180452TT HRP20180452T1 (hr)	2013-08-06	2018-03-16	Peptidi

Country Status (32)

Country	Link
US (2)	US9938329B2 (hr)
EP (1)	EP3030259B1 (hr)
JP (1)	JP6476181B2 (hr)
KR (1)	KR102431507B1 (hr)
CN (1)	CN105636980B (hr)
AU (1)	AU2014304108B2 (hr)
BR (1)	BR112016002572A2 (hr)
CA (1)	CA2920321C (hr)
CY (1)	CY1120212T1 (hr)
DK (1)	DK3030259T3 (hr)
ES (1)	ES2664045T3 (hr)
GB (1)	GB201314052D0 (hr)
HK (1)	HK1219058A1 (hr)
HR (1)	HRP20180452T1 (hr)
HU (1)	HUE038569T2 (hr)
IL (1)	IL243892B (hr)
LT (1)	LT3030259T (hr)
MX (1)	MX369412B (hr)
MY (1)	MY177371A (hr)
NO (1)	NO3030259T3 (hr)
NZ (1)	NZ717350A (hr)
PE (1)	PE20160778A1 (hr)
PH (1)	PH12016500218A1 (hr)
PL (1)	PL3030259T3 (hr)
PT (1)	PT3030259T (hr)
RS (1)	RS57196B1 (hr)
RU (1)	RU2676149C2 (hr)
SG (1)	SG11201600895SA (hr)
SI (1)	SI3030259T1 (hr)
UA (1)	UA120746C2 (hr)
WO (1)	WO2015019302A2 (hr)
ZA (1)	ZA201600729B (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201314052D0 (en) *	2013-08-06	2013-09-18	Apitope Int Nv	Peptides
AU2015370415B2 (en) *	2014-12-24	2022-06-02	Worg Pharmaceuticals (Zhejiang) Co., Ltd.	Composition
AU2018206356A1 (en) *	2017-01-04	2019-07-18	Worg Pharmaceuticals (Zhejiang) Co., Ltd.	Therapeutic method using tolerogenic peptides
EP3369743A1 (en) *	2017-03-01	2018-09-05	advanceCOR GmbH	Cyclic peptides for the treatment of graves' disease
EP3622962A1 (en) *	2018-09-14	2020-03-18	advanceCOR GmbH	Short cyclic peptides for the treatment of graves' disease
GB201909774D0 (en)	2019-07-08	2019-08-21	Apitope Tech Bristol Limited	Method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE145240T1 (de) *	1989-12-14	1996-11-15	Brahms Diagnostica Gmbh	Polypeptide mit thyrotropinrezeptor-aktivität, kodierende nukleinsäuresequenzen für solche rezeptoren und verwendung dieser polypeptide
JP5431628B2 (ja) *	2000-08-21	2014-03-05	アピトープテクノロジー（ブリストル）リミテッド	ペプチド調査方法
GB0202399D0 (en)	2002-02-01	2002-03-20	Univ Bristol	Peptide
FR2842812A1 (fr) *	2002-07-26	2004-01-30	Pf Medicament	Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) *	2004-12-10	2006-07-20	Tokyo Univ Of Agriculture & Technology	蛋白質の溶解度向上方法
JP2009517015A (ja) *	2005-11-21	2009-04-30	ドクトルフェニングビオメッドゲゼルシャフトミットベシュレンクテルハフツング	組換えポリペプチドならびにｔｓｈレセプターに対する自己抗体を検出及び／又は定量化する方法
NZ576032A (en) *	2006-10-12	2012-03-30	Genentech Inc	Antibodies to lymphotoxin-alpha
GB0723712D0 (en) *	2007-12-04	2008-01-16	Apitope Technology Bristol Ltd	Peptides
GB0908515D0 (en) *	2009-05-18	2009-06-24	Apitope Technology Bristol Ltd	Peptide
GB201314052D0 (en) *	2013-08-06	2013-09-18	Apitope Int Nv	Peptides

2013
- 2013-08-06 GB GB201314052A patent/GB201314052D0/en not_active Ceased
2014
- 2014-08-06 RU RU2016107873A patent/RU2676149C2/ru active
- 2014-08-06 RS RS20180316A patent/RS57196B1/sr unknown
- 2014-08-06 JP JP2016532780A patent/JP6476181B2/ja active Active
- 2014-08-06 AU AU2014304108A patent/AU2014304108B2/en active Active
- 2014-08-06 EP EP14772444.7A patent/EP3030259B1/en active Active
- 2014-08-06 CA CA2920321A patent/CA2920321C/en active Active
- 2014-08-06 NZ NZ717350A patent/NZ717350A/en unknown
- 2014-08-06 UA UAA201602098A patent/UA120746C2/uk unknown
- 2014-08-06 PT PT147724447T patent/PT3030259T/pt unknown
- 2014-08-06 US US14/910,372 patent/US9938329B2/en active Active
- 2014-08-06 MX MX2016001744A patent/MX369412B/es active IP Right Grant
- 2014-08-06 SG SG11201600895SA patent/SG11201600895SA/en unknown
- 2014-08-06 PE PE2016000223A patent/PE20160778A1/es unknown
- 2014-08-06 PL PL14772444T patent/PL3030259T3/pl unknown
- 2014-08-06 ES ES14772444.7T patent/ES2664045T3/es active Active
- 2014-08-06 WO PCT/IB2014/063739 patent/WO2015019302A2/en active Application Filing
- 2014-08-06 HU HUE14772444A patent/HUE038569T2/hu unknown
- 2014-08-06 NO NO14772444A patent/NO3030259T3/no unknown
- 2014-08-06 BR BR112016002572A patent/BR112016002572A2/pt not_active IP Right Cessation
- 2014-08-06 CN CN201480053788.0A patent/CN105636980B/zh active Active
- 2014-08-06 MY MYPI2016000224A patent/MY177371A/en unknown
- 2014-08-06 DK DK14772444.7T patent/DK3030259T3/en active
- 2014-08-06 SI SI201430666T patent/SI3030259T1/en unknown
- 2014-08-06 LT LTEP14772444.7T patent/LT3030259T/lt unknown
- 2014-08-06 KR KR1020167005185A patent/KR102431507B1/ko active IP Right Grant
2016
- 2016-02-01 IL IL24389216A patent/IL243892B/en active IP Right Grant
- 2016-02-01 PH PH12016500218A patent/PH12016500218A1/en unknown
- 2016-02-02 ZA ZA2016/00729A patent/ZA201600729B/en unknown
- 2016-06-21 HK HK16107175.4A patent/HK1219058A1/zh unknown
2018
- 2018-02-23 US US15/903,379 patent/US10730919B2/en active Active
- 2018-03-16 HR HRP20180452TT patent/HRP20180452T1/hr unknown
- 2018-03-26 CY CY20181100337T patent/CY1120212T1/el unknown

Also Published As

Publication number	Publication date
US20160185833A1 (en)	2016-06-30
CN105636980B (zh)	2021-05-04
MX2016001744A (es)	2016-05-18
NZ717350A (en)	2019-03-29
RU2676149C2 (ru)	2018-12-26
CA2920321C (en)	2022-10-18
KR102431507B1 (ko)	2022-08-10
SG11201600895SA (en)	2016-03-30
US20180327463A1 (en)	2018-11-15
AU2014304108B2 (en)	2018-03-08
CY1120212T1 (el)	2018-12-12
LT3030259T (lt)	2018-05-10
CN105636980A (zh)	2016-06-01
IL243892A0 (en)	2016-04-21
PH12016500218A1 (en)	2016-04-25
WO2015019302A3 (en)	2015-08-27
ZA201600729B (en)	2019-12-18
SI3030259T1 (en)	2018-07-31
HK1219058A1 (en)	2017-03-24
EP3030259B1 (en)	2017-12-27
GB201314052D0 (en)	2013-09-18
MX369412B (es)	2019-11-07
ES2664045T3 (es)	2018-04-18
RS57196B1 (sr)	2018-07-31
KR20160036059A (ko)	2016-04-01
DK3030259T3 (en)	2018-04-16
UA120746C2 (uk)	2020-02-10
IL243892B (en)	2019-11-28
US10730919B2 (en)	2020-08-04
CA2920321A1 (en)	2015-02-12
EP3030259A2 (en)	2016-06-15
PL3030259T3 (pl)	2018-07-31
NO3030259T3 (hr)	2018-05-26
US9938329B2 (en)	2018-04-10
JP6476181B2 (ja)	2019-02-27
HUE038569T2 (hu)	2018-10-29
AU2014304108A1 (en)	2016-02-25
JP2016527304A (ja)	2016-09-08
BR112016002572A2 (pt)	2017-09-12
PT3030259T (pt)	2018-03-20
PE20160778A1 (es)	2016-08-06
WO2015019302A2 (en)	2015-02-12
RU2016107873A (ru)	2017-09-12
MY177371A (en)	2020-09-14

Publication	Publication Date	Title
IL245744A0 (en)	2016-07-31	Therapeutic peptides
HK1216757A1 (zh)	2016-12-02	肽化合物
HK1219983A1 (zh)	2017-04-21	治療性肽
HK1214829A1 (zh)	2016-08-05	治療肽
GB201311475D0 (en)	2013-08-14	Polypeptides
HRP20180452T1 (hr)	2018-06-01	Peptidi
PL3061771T3 (pl)	2020-10-19	Nowy peptyd o czterech połączonych epitopach dla ctl
GB201308057D0 (en)	2013-06-12	Protein
HK1211596A1 (en)	2016-05-27	Peptide
HK1198769A1 (en)	2015-06-05	Novel peptide
GB201309421D0 (en)	2013-07-10	Polypeptides
HK1211595A1 (en)	2016-05-27	Peptide
GB201315130D0 (en)	2013-10-09	Peptides
GB201401955D0 (en)	2014-03-19	Protein
PL3080276T3 (pl)	2018-08-31	Polipeptydy toksyczne dla owadów
GB201316660D0 (en)	2013-11-06	Peptides
GB201300381D0 (en)	2013-02-20	Peptides
GB201305465D0 (en)	2013-05-08	Novel peptides
GB201317839D0 (en)	2013-11-20	Anti-Microbial peptides
GB201322749D0 (en)	2014-02-05	Cyclic peptide
GB201302031D0 (en)	2013-03-20	Protein
GB201302030D0 (en)	2013-03-20	Protein